Howie and Harlan are joined by Scott Berkowitz ’03, cardiologist and chief population health officer at Johns Hopkins Medicine, to discuss the necessity of moving from fee-for-service to value-based care delivery to improve outcomes for all. Harlan highlights the dangers of misinformation about Ivermectin. Howie reports on the potential conflicts of interest created by device manufacturers’ payments to cardiologists.
Links:
Johns Hopkins Community Health Partnership
“Association of a Care Coordination Model With Health Care Costs and Utilization”
“Planning for the Future of Population Health: The Johns Hopkins Medicine Experience”
“Califf’s long day on Capitol Hill”
“The FDA Deleted Its Viral Ivermectin Tweets. Now There’s Even More Misinformation.”
“Philly Nonprofit Awarded $48 Million to Apply AI in Search for New Uses for Approved Drugs
“Effect of Early Treatment with Ivermectin among Patients with Covid-19”
“FDA settles lawsuit over ivermectin content that doctors claimed harmed their practice”
Learn more about the MBA for Executives program at Yale SOM.
Email Howie and Harlan comments or questions.
“The Yale School of Management is the graduate business school of Yale University, a private research university in New Haven, Connecticut.”
